DUBLIN, August 15, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Asthma Therapeutics Market 2016-2020" report to their offering.
The report forecasts the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.
One of the key trends for market growth will be innovative technologies for drug delivery. The industry's shift toward electronic systems technology like smart technology and EHR brings the level of perspective and accessibility across healthcare specialties. This reduces cost when administering expensive medications. Other recent advances include integration of add-on devices such as spacers, breath-actuated devices, and valved holding chambers in inhalers. They help in reducing oropharyngeal deposition of inhaled corticosteroids and minimizes side effects.
According to the report, one of the key drivers for market growth will be huge market potential for mAbs. mAbs will have a high uptake for the treatment of asthma, owing to the development of target specific drugs. mAbs blocking IgE are specifically approved for the treatment of allergic asthma. Asthmatic patients with phenotypes of severe refractory asthma will benefit from these mAbs. mAbs against immunoglobulin or specific cytokines, which are known to be important in the initiation or persistence of asthmatic inflammation are being developed. Xolair was the first mAb approved for the treatment of allergic asthma.
Further, the report states that once of the challenges for the market will be increased preference for CAM.
- Boehringer Ingelheim
- F. Hoffmann-La Roche
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Pipeline portfolio
PART 06: Market landscape
PART 07: Key buying criteria for asthma drugs
PART 08: Market segmentation by type of treatment
PART 09: Market segmentation by drug class
PART 10: Segmentation by route of administration
PART 11: Drug delivery devices market for asthma drugs
PART 12: Geographical segmentation
PART 13: Market drivers
PART 14: Impact of drivers
PART 15: Market challenges
PART 16: Impact of drivers and challenges
PART 17: Market trends
PART 18: Vendor landscape
PART 19: Key vendor analysis
PART 20: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/s7df5f/global_asthma
Related Topics: Asthma Drugs
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets